Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-20-075229
Filing Date
2020-06-19
Accepted
2020-06-19 16:15:42
Documents
7
Effectiveness Date
2020-06-19

Document Format Files

Seq Description Document Type Size
1 DOCUMENT S-3ASR tm2022875-1_s3asr.htm S-3ASR 441134
2 EXHIBIT 5.1 tm2022875-1_ex5x1.htm EX-5.1 8423
3 EXHIBIT 23.1 tm2022875-1_ex23x1.htm EX-23.1 3298
4 EXHIBIT 23.2 tm2022875-1_ex23x2.htm EX-23.2 3333
5 GRAPHIC lg_ptctherapeutic-bw.jpg GRAPHIC 84708
6 GRAPHIC lg_morganlewis-bw.jpg GRAPHIC 61890
7 GRAPHIC lh_morganlewis-bw.jpg GRAPHIC 163281
  Complete submission text file 0001104659-20-075229.txt   862941
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-239308 | Film No.: 20975808
SIC: 2834 Pharmaceutical Preparations